Literature DB >> 2042989

The progressive systemic sclerosis/systemic lupus overlap: an unusual clinical progression.

R A Asherson1, H Angus, J A Mathews, O Meyers, G R Hughes.   

Abstract

Three patients with the unusual combinations of discoid lupus, systemic lupus erythematosus (SLE), and progressive systemic sclerosis (PSS) are reported. The first patient developed PSS eight years after a diagnosis of discoid lupus had been made and this was complicated by myositis six years later. The second patient developed PSS more than 20 years after being diagnosed as having SLE. The third patient developed SLE with predominant features of urticarial vasculitis six years after PSS. Mild myositis also ensued. There were no antibodies to U1RNP demonstrable in any of these patients. The clinical progression of SLE to PSS or vice versa in the absence of features of mixed connective tissue disease is distinctly uncommon.

Entities:  

Mesh:

Year:  1991        PMID: 2042989      PMCID: PMC1004420          DOI: 10.1136/ard.50.5.323

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  5 in total

1.  Coexistence of lupus erythematosus and scleroderma in light of immunopathological investigations.

Authors:  T Chorzelski; S Jablónska
Journal:  Acta Derm Venereol       Date:  1970       Impact factor: 4.437

2.  Familial occurrence of progressive systemic sclerosis and systemic lupus erythematosus.

Authors:  R H Flores; M B Stevens; F C Arnett
Journal:  J Rheumatol       Date:  1984-06       Impact factor: 4.666

3.  Correlation of a precipitin reaction to an RNAprotein antigen and a low prevalence of nephritis in patients with systemic lupus erythematosus.

Authors:  M Reichlin; M Mattioli
Journal:  N Engl J Med       Date:  1972-04-27       Impact factor: 91.245

4.  Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA).

Authors:  G C Sharp; W S Irvin; E M Tan; R G Gould; H R Holman
Journal:  Am J Med       Date:  1972-02       Impact factor: 4.965

5.  Progressive systemic sclerosis (PSS) and localized scleroderma (morphea) with positive LE cell test and unusual systemic manifesstations compatible with systemic lupus erythematous (SLE): presentation of 14 cases including one set of identical twins, one with scleroderma dn the other with SLE. Review of the literature.

Authors:  E L Dubois; S Chandor; G J Friou; M Bischel
Journal:  Medicine (Baltimore)       Date:  1971-05       Impact factor: 1.889

  5 in total
  4 in total

Review 1.  Systemic lupus erythematosus.

Authors:  M S Klein-Gitelman; M L Miller
Journal:  Indian J Pediatr       Date:  1996 Jul-Aug       Impact factor: 1.967

2.  A localised morphoea/idiopathic polymyositis overlap.

Authors:  H M al Attia; H Ezzeddin; T Khader; M A Aref
Journal:  Clin Rheumatol       Date:  1996-05       Impact factor: 2.980

Review 3.  [Lupus erythematosus. Wide range of symptoms through clinical variation, associated diseases and imitators].

Authors:  E Aberer
Journal:  Hautarzt       Date:  2010-08       Impact factor: 0.751

4.  Multiple avascular necrosis in a patient with systemic lupus erythematosus/systemic sclerosis overlap syndrome.

Authors:  Javier Alberto Cavallasca; Hugo Armando Laborde; Mariela Beatriz Araujo; Gustavo Guillermo Nasswetter
Journal:  Clin Rheumatol       Date:  2005-01-20       Impact factor: 2.980

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.